Guinan, Eva C.
Dana-Farber Cancer Institute,
United States
2025 Rank: 86998
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2378 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86998 | 98444 |
| Total Cites | 8963 | 9897 |
| H-index | 47 | 47 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 101 | 101 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1283 | 1367 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 4246 | 4605 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7857 | 8440 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
9.44%
|
|
Guinan, Eva C.
Harvard Medical School,
United States
2024 Rank: 85266
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2371 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85266 | 91860 |
| Total Cites | 8530 | 9414 |
| H-index | 44 | 46 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 95 | 95 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 1250 | 1328 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 4171 | 4523 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7487 | 8032 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
9.39%
|
|
Guinan, Eva C.
Dana-Farber Cancer Institute,
United States
2023 Rank: 84346
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2385 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84346 | 91222 |
| Total Cites | 8074 | 8918 |
| H-index | 42 | 44 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 90 | 90 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1228 | 1305 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 4060 | 4404 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7078 | 7596 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
9.46%
|
|
Guinan, Eva C.
Harvard Medical School,
United States
2022 Rank: 79217
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2291 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79217 | 86675 |
| Total Cites | 7558 | 8340 |
| H-index | 41 | 43 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 86 | 86 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1191 | 1265 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 3904 | 4228 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6640 | 7117 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
9.38%
|
|